The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
24/7 Wall St8d
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
Study Shows Diabetes Drugs’ Potential Beyond Weight Loss
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...
pharmaphorum2d
Novo Nordisk’s diabetes treatments approved in EU
The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes ... all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation ...
EurekAlert!3d
Many Greenlanders face 10 times higher risk of diabetes – exercise may be their only solution
A significant portion of the Greenlandic Inuit population carries a genetic variant that increases their risk of type 2 diabetes tenfold. Now, researchers from the University of Copenhagen have ...
U.S. News & World Report6d
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule
California aimed to disrupt pharmaceutical market When he announced the Civica deal in early 2023, Newsom made it ... brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi ...
Capital Public Radio6d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
When he announced the Civica deal in early 2023, Newsom made it clear that the ... The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — cut prices between ...
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.
Everyday Health7d
Over-the-Counter (OTC) Insulin: What You Need to Know
Nonprescription insulin is made from older formulations of diabetes ... Walmart teamed up with drugmaker Novo Nordisk to sell its own brand, called ReliOn insulin, which sells for as little ...